Alternative approaches include detailed case reports for abnormal early-onset AD patients, or case–control studies on early-onset AD patients, matching factors such as age, sex, region, AD genes, or APOE4 pathogenic mutations to explore the potential association between blood transfusion and early-onset AD cases. The gene discussed is APOE; the disease is Alzheimer disease.